Expertise in
7
conditions

Dr. Jeffrey T. Yorio

Oncology
6204 Balcones Dr, 
Austin, TX 
Accepting New Patients
Offers Telehealth
Expertise in
7
conditions
6204 Balcones Dr, 
Austin, TX 

Overview

Jeffrey Yorio is an Oncologist practicing medicine in Austin, Texas.

Dr. Yorio is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Myelodysplastic Syndrome (MDS), and Paroxysmal Nocturnal Hemoglobinuria (PNH).

Dr. Yorio is board certified in The American Board Of Internal Medicine - Hematology, The American Board Of Internal Medicine - Medical Oncology, and The American Board Of Internal Medicine - Internal Medicine. He is actively involved in clinical research, co-authoring 12 peer reviewed articles and participating in 4 clinical trials. Dr. Yorio is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in TX

Board Certifications

The American Board Of Internal Medicine - Hematology
The American Board Of Internal Medicine - Medical Oncology
The American Board Of Internal Medicine - Internal Medicine

Fellowships

UT MD Anderson Cancer Center

Hospital Affiliations

Ascension Seton Medical Center Austin
North Austin Medical Center
St David's Medical Center
Ascension Seton Medical Center Austin
Ascension Seton Northwest
Ascension Seton Williamson
Dell Seton Medical Center At The University Of Texas

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
FirstCare
  • HMO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Moda Health
  • EPO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Sendero
  • HMO
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
US Health and Life
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 21 Less Insurance Carriers -

Locations

Texas Oncology
6204 Balcones Dr, Austin, TX 78731

Additional Areas of Focus

Dr. Yorio has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients With High Risk Resected Melanoma
A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients With High Risk Resected Melanoma
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Procedure, Biological
Study Drugs: Ipilimumab, Pembrolizumab, Recombinant Interferon Alfa-2b
Study Phase: Phase 3
A Phase 2 Study of Brentuximab Vedotin in Combination With Pembrolizumab in Participants With Metastatic Solid Malignancies
A Phase 2 Study of Brentuximab Vedotin in Combination With Pembrolizumab in Participants With Metastatic Solid Malignancies
Enrollment Status: Completed
Publish Date: July 06, 2026
Intervention Type: Drug
Study Drugs: Brentuximab vedotin, Pembrolizumab
Study Phase: Phase 2
A Phase 2, Randomized, Open-Label Study of Trilaciclib Administered With First-Line Platinum-Based Chemotherapy and Avelumab Maintenance Therapy in Patients With Untreated, Locally Advanced or Metastatic Urothelial Carcinoma (PRESERVE 3)
A Phase 2, Randomized, Open-Label Study of Trilaciclib Administered With First-Line Platinum-Based Chemotherapy and Avelumab Maintenance Therapy in Patients With Untreated, Locally Advanced or Metastatic Urothelial Carcinoma (PRESERVE 3)
Enrollment Status: Terminated
Publish Date: September 08, 2025
Intervention Type: Drug
Study Drugs: Trilaciclib, Gemcitabine, Cisplatin, Carboplatin, Avelumab
Study Phase: Phase 2
A Phase 2 Open-Label Multicenter Study to Evaluate the Safety and Efficacy of Selinexor in Combination With Pembrolizumab in Recurrent Advanced Melanoma
A Phase 2 Open-Label Multicenter Study to Evaluate the Safety and Efficacy of Selinexor in Combination With Pembrolizumab in Recurrent Advanced Melanoma
Enrollment Status: Terminated
Publish Date: August 23, 2024
Intervention Type: Drug
Study Drugs: Selinexor, Pembrolizumab
Study Phase: Phase 2
View 3 Less Clinical Trials

12 Total Publications

Estimated cost of VEGFR TKI associated adverse events in metastatic renal cell carcinoma patients.
Estimated cost of VEGFR TKI associated adverse events in metastatic renal cell carcinoma patients.
Journal: BMC health services research
Published: April 23, 2024
Similar Doctors
Expertise in
10
conditions
Expertise in
10
conditions
Referral may be required

Texas Oncology

6204 Balcones Dr, 
Austin, TX 
 (0.1 miles away)
512-427-9400
Languages Spoken:
English, Spanish, Vietnamese
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Teneriello, MD is a gynecologic oncologist specializing in cancers of the reproductive organs at Ascension Seton in Austin, Texas. Dr. Teneriello delivers personalized care for women. He starts by listening to understand you and your health needs. Then, he works with you to create a cancer care plan that's right for you. Dr. Teneriello provides minimally invasive surgery to treat ovarian, vulvar, endometrial or uterine and cervical cancer. Dr. Teneriello is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Malignant Mixed Mullerian Tumor, and Testicular Yolk Sac Tumor. Dr. Teneriello is board certified in The American Board Of Obstetrics And Gynecology - Gynecologic Oncology and The American Board Of Obstetrics And Gynecology - Obstetrics And Gynecology. Dr. Teneriello is currently accepting new patients.

Expertise in
10
conditions
Expertise in
10
conditions
Referral may be required

Texas Oncology

12221 Renfert Way, Ste 350, 
Austin, TX 
 (5.5 miles away)
737-610-5200
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Paul Loar-Iii is an Oncologist practicing medicine in Austin, Texas. Dr. Loar-Iii is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Malignant Mixed Mullerian Tumor, Ovarian Carcinosarcoma, Salpingo-Oophorectomy, and Bladder Reconstruction. Dr. Loar-Iii is board certified in The American Board Of Obstetrics And Gynecology - Gynecologic Oncology and The American Board Of Obstetrics And Gynecology - Obstetrics And Gynecology. Dr. Loar-Iii is currently accepting new patients.

Expertise in
7
conditions
Expertise in
7
conditions
Referral may be required

Texas Oncology

6204 Balcones Dr, 
Austin, TX 
 (0.1 miles away)
512-427-9400
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Debra Patt is an Oncologist practicing medicine in Austin, Texas. Dr. Patt is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Squamous Cell Carcinoma of the Anal Canal (SCAC), and Triple-Negative Breast Cancer. Dr. Patt is board certified in The American Board Of Internal Medicine - Medical Oncology and The American Board Of Preventive Medicine - Clinical Informatics. Dr. Patt is currently accepting new patients.

Frequently Asked Questions about Dr. Jeffrey T. Yorio

How do I make an appointment with Dr. Jeffrey T. Yorio?

You can book an appointment with Dr. Jeffrey T. Yorio by calling their office at 512-427-9400. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jeffrey T. Yorio a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jeffrey T. Yorio is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jeffrey T. Yorio specialize in?

While Dr. Jeffrey T. Yorio is a Oncology, they have specific expertise in Lung Cancer, Pleuropulmonary Blastoma, and Myelodysplastic Syndrome (MDS). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Jeffrey T. Yorio participate in research or clinical trials?

Yes. Dr. Jeffrey T. Yorio has published 12 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Jeffrey T. Yorio's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jeffrey T. Yorio accept my insurance?

Dr. Jeffrey T. Yorio accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 512-427-9400 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Yorio's expertise for a condition
ConditionClose
    View All 89 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile